Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Brotherton, Marie Christine ^a,b   Bourassa, Sylvie ^c   Leprohon, Philippe ^a,b   Légaré, Danielle ^a,b   Poirier, Guy G ^c   Droit, Arnaud ^c   Ouellette, Marc ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ANIMALS; ANTIMONY; DRUG RESISTANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENOME, PROTOZOAN; LEISHMANIA INFANTUM; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOMICS; PROTOZOAN PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84894277564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081899     Document Type: Article

References (68)

1. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366: 1561-1577. doi:10.1016/S0140-6736(05)67629-5. PubMed: 16257344.
2. Alvar J, Croft S, Olliaro P (2006) Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 61: 223-274. doi:10.1016/S0065-308X(05) 61006-8. PubMed: 16735166.
3. Lira R, Sundar S, Makharia A, Kenney R, Gam A et al. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180: 564-567. doi:10.1086/314896. PubMed: 10395884.
4. Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6: 849-854. doi:10.1046/j.1365-3156.2001.00778.x. PubMed: 11703838.
5. Thakur CP, Dedet JP, Narain S, Pratlong F (2001) Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Trans R Soc Trop Med Hyg 95: 187-189.
6. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK (2007) Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med 356: 2571-2581. doi:10.1056/NEJMoa066536. PubMed: 17582067.
7. Sundar S, Rosenkaimer F, Makharia MK, Goyal AK, Mandal AK et al. (1998) Trial of oral miltefosine for visceral leishmaniasis. Lancet 352: 1821-1823. doi:10.1016/S0140-6736(98)04367-0. PubMed: 9851383.
8. Olliaro P, Sundar S (2009) Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Trop Med Int Health 14: 88-92. doi:10.1111/j.1365-3156.2008.02195.x. PubMed: 19121150.
9. Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M et al. (2006) Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 43: 917-924. doi:10.1086/507530. PubMed: 16941377.
10. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-882. PubMed: 17938629.
11. Shaked-Mishan P, Ulrich N, Ephros M, Zilberstein D (2001) Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem 276: 3971-3976. doi:10.1074/jbc.M005423200. PubMed: 11110784.
12. Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S et al. (2004) Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 279: 31010-31017. doi:10.1074/ jbc.M403959200. PubMed: 15138256.
13. Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M (2005) Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol 57: 1690-1699. doi:10.1111/j.1365-2958.2005.04782.x. PubMed: 16135234.
14. Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T et al. (2005) Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 49: 4616-4621. doi:10.1128/AAC.49.11.4616-4621.2005. PubMed: 16251303.
15. Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R (2010) Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 65: 496-507. doi:10.1093/jac/dkp468. PubMed: 20067981.
16. Ouellette M, Borst P (1991) Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Res Microbiol 142: 737-746. doi:10.1016/0923-2508(91)90089-S. PubMed: 1961984.
17. Grondin K, Papadopoulou B, Ouellette M (1993) Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res 21: 1895-1901. doi:10.1093/nar/21.8.1895. PubMed: 8098523.
18. Grondin K, Haimeur A, Mukhopadhyay R, Rosen BP, Ouellette M (1997) Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 16: 3057-3065. doi:10.1093/emboj/16.11.3057. PubMed: 9214623.
19. Haimeur A, Brochu C, Genest P, Papadopoulou B, Ouellette M (2000) Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Mol Biochem Parasitol 108: 131-135. doi:10.1016/S0166-6851(00)00187-0. PubMed: 10802326.
20. Leprohon P, Légaré D, Raymond F, Madore E, Hardiman G et al. (2009) Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res 37: 1387-1399. doi:10.1093/nar/gkn1069. PubMed: 19129236.
21. Mittal MK, Rai S, Ashutosh, Ravinder, Gupta S et al. (2007) Characterization of natural antimony resistance in Leishmania donovani isolates. Am J Trop Med Hyg 76: 681-688. PubMed: 17426170.
22. Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I et al. (2007) Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59: 204-211. PubMed: 17213267.
23. Mukhopadhyay R, Dey S, Xu N, Gage D, Lightbody J et al. (1996) Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc Natl Acad Sci U S A 93: 10383-10387. doi:10.1073/pnas.93.19. 10383. PubMed: 8816809.
24. Légaré D, Papadopoulou B, Roy G, Mukhopadhyay R, Haimeur A et al. (1997) Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania. Exp Parasitol 87: 275-282. doi:10.1006/expr.1997. 4222. PubMed: 9371094.
25. Haimeur A, Guimond C, Pilote S, Mukhopadhyay R, Rosen BP et al. (1999) Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arseniteresistant Leishmania. Mol Microbiol 34: 726-735. doi:10.1046/j.1365-2958.1999.01634.x. PubMed: 10564512.
26. Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A et al. (2003) Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res 31: 5886-5896. doi:10.1093/nar/gkg806. PubMed: 14530437.
27. Mukherjee A, Roy G, Guimond C, Ouellette M (2009) The gamma-glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants. Mol Microbiol 74: 914-927. doi:10.1111/j.1365-2958. 2009.06907.x. PubMed: 19818018.
28. Mandal G, Wyllie S, Singh N, Sundar S, Fairlamb AH et al. (2007) Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 134: 1679-1687. PubMed: 17612420.
29. Singh N, Almeida R, Kothari H, Kumar P, Mandal G et al. (2007) Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology 134: 777-787. doi:10.1017/S0031182007002284. PubMed: 17306059.
30. Ashutosh, Sundar S, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56: 143-153. doi:10.1099/jmm.0.46841- 0. PubMed: 17244793.
31. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J et al. (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6: 88-101. PubMed: 17050524.
32. El Fadili K, Drummelsmith J, Roy G, Jardim A, Ouellette M (2009) Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen. Exp Parasitol 123: 51-57. doi:10.1016/j.exppara.2009.05.013. PubMed: 19500579.
33. Kumar A, Sisodia B, Misra P, Sundar S, Shasany AK et al. (2010) Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani. Br J Clin Pharmacol 70: 609-617. doi:10.1111/j.1365-2125.2010.03716.x. PubMed: 20840452.
34. Biyani N, Singh AK, Mandal S, Chawla B, Madhubala R (2011) Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani. Mol Biochem Parasitol 179: 91-99. doi:10.1016/j.molbiopara. 2011.06.004. PubMed: 21736901.
35. Walker J, Gongora R, Vasquez JJ, Drummelsmith J, Burchmore R et al. (2012) Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol Biochem Parasitol 183: 166-176. doi:10.1016/j.molbiopara.2012.03.002. PubMed: 22449941.
36. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH et al. (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 21: 2143-2156. doi:10.1101/gr.123430.111. PubMed: 22038251.
37. Mukherjee A, Boisvert S, do Monte-Neto RL, Coelho AC, Raymond F et al. (2013) Telomeric gene deletion and intrachromosomal amplification in antimony resistant Leishmania. Mol Microbiol.
38. El Fadili K, Messier N, Leprohon P, Roy G, Guimond C et al. (2005) Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 49: 1988-1993. doi:10.1128/AAC.49.5.1988-1993.2005. PubMed: 15855523.
39. Leprohon P, Légaré D, Ouellette M (2009) Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials. Antimicrob Agents Chemother 53: 2646-2649. doi:10.1128/AAC.01474- 08. PubMed: 19307364.
40. Moreira W, Leprohon P, Ouellette M (2011) Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis 2: e201.
41. Brotherton MC, Racine G, Ouameur AA, Leprohon P, Papadopoulou B et al. (2012) Analysis of Membrane-Enriched and High Molecular Weight Proteins in Leishmania infantum Promastigotes and Axenic Amastigotes. J Proteome Res 11: 3974-3985. doi:10.1021/pr201248h. PubMed: 22716046.
42. Brotherton MC, Racine G, Foucher AL, Drummelsmith J, Papadopoulou B et al. (2010) Analysis of stage-specific expression of basic proteins in Leishmania infantum. J Proteome Res 9: 3842-3853. doi:10.1021/pr100048m. PubMed: 20583757.
43. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858. doi:10.1021/ac950914h. PubMed: 8779443.
44. Havlis J, Thomas H, Sebela M, Shevchenko A (2003) Fast-response proteomics by accelerated in-gel digestion of proteins. Anal Chem 75: 1300-1306. doi:10.1021/ac026136s. PubMed: 12659189.
45. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH et al. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6: 1638-1655. doi:10.1074/mcp.T600050-MCP200. PubMed: 17533153.
46. Raymond F, Boisvert S, Roy G, Ritt JF, Légaré D et al. (2012) Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res 40: 1131-1147. doi:10.1093/nar/gkr834. PubMed: 21998295.
47. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC et al. (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39: 839-847. doi:10.1038/ng2053. PubMed: 17572675.
48. Aslett M, Aurrecoechea C, Berriman M, Brestelli J, Brunk BP et al. (2010) TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res 38: D457-D462. doi:10.1093/nar/gkq373. PubMed: 19843604.
49. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760. doi:10.1093/ bioinformatics/btp324. PubMed: 19451168.
50. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079. doi:10.1093/bioinformatics/btp352. PubMed: 19505943.
51. Lassmann T, Hayashizaki Y, Daub CO (2011) SAMStat: monitoring biases in next generation sequencing data. Bioinformatics 27: 130-131. doi:10.1093/bioinformatics/btq614. PubMed: 21088025.
52. Papadopoulou B, Roy G, Ouellette M (1992) A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J 11: 3601-3608. PubMed: 1396560.
53. Sterkers Y, Lachaud L, Bourgeois N, Crobu L, Bastien P et al. (2012) Novel insights into genome plasticity in Eukaryotes: mosaic aneuploidy in Leishmania. Mol Microbiol 86: 15-23. PubMed: 22857263.
54. Wilson ME, Hardin KK (1990) The major Leishmania donovani chagasi surface glycoprotein in tunicamycin-resistant promastigotes. J Immunol 144: 4825-4834. PubMed: 2191040.
55. Soteriadou KP, Tzinia AK, Mamalaki A, Phelouzat MA, Lawrence F et al. (1994) Expression of the major surface glycoprotein of Leishmania, gp63, in wild-type and sinefungin-resistant promastigotes. Eur J Biochem 223: 61-68. doi:10.1111/j.1432-1033.1994.tb18966.x. PubMed: 8033909.
56. Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P (2010) Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Int J Antimicrob Agents 36: 50-57. doi:10.1016/j.ijantimicag.2010.03.012. PubMed: 20427152.
57. Lawrence F, Robert-Gero M (1985) Induction of heat shock and stress proteins in promastigotes of three Leishmania species. Proc Natl Acad Sci U S A 82: 4414-4417. doi:10.1073/pnas.82.13.4414. PubMed: 3859870.
58. Brochu C, Haimeur A, Ouellette M (2004) The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania. Cell Stress Chaperones 9: 294-303. doi:10.1379/CSC-15R1.1. PubMed: 15544167.
59. Sereno D, Holzmuller P, Mangot I, Cuny G, Ouaissi A et al. (2001) Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother 45: 2064-2069. doi:10.1128/AAC.45.7.2064-2069.2001. PubMed: 11408224.
60. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R et al. (2002) Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ 9: 53-64. doi:10.1038/sj.cdd.4400952. PubMed: 11803374.
61. Sudhandiran G, Shaha C (2003) Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Biol Chem 278: 25120-25132. doi:10.1074/jbc.M301975200. PubMed: 12707265.
62. Duesberg P, Li R, Sachs R, Fabarius A, Upender MB et al. (2007) Cancer drug resistance: the central role of the karyotype. Drug Resist Updat 10: 51-58. doi:10.1016/j.drup.2007.02.003. PubMed: 17387035.
63. Selmecki A, Forche A, Berman J (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313: 367-370. doi:10.1126/science.1128242. PubMed: 16857942.
64. Ubeda JM, Légaré D, Raymond F, Ouameur AA, Boisvert S et al. (2008) Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol 9: R115. doi:10.1186/gb-2008-9-7-r115. PubMed: 18638379.
65. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M et al. (2007) Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924. doi:10.1126/science.1142210. PubMed: 17702937.
66. Pathak MK, Yi T (2001) Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 167: 3391-3397. PubMed: 11544330.
67. Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R et al. (2013) Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol 135: 344-349. doi:10.1016/j.exppara.2013.07.018. PubMed: 23928349.
68. Ashutosh, Garg M, Sundar S, Duncan R, Nakhasi HL et al. (2012) Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance. Antimicrob Agents Chemother 56: 518-525. doi:10.1128/AAC.00736-11. PubMed: 22064540.